What's New at CBER
- CBER Vacancy: Director, Office of Blood Research and Review (OBRR)
Posted: 3/28/2018 - User Fee Billable Biologic Products and Potencies Approved Under Section 351 of the PHS Act
Posted: 3/28/2018 - Zostavax (Herpes Zoster Vaccine) Questions and Answers
Updated: 3/28/2018
.png)
No hay comentarios:
Publicar un comentario